Sandeep R. Sehdev
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Primary Nodal Poroid Hidradenocarcinoma With YAP1::NUTM1 Fusion: Report of a Rare Case.
Journal: Journal of cutaneous pathology
Published: May 14, 2026
Nanomedicines from the patient perspective - 30 years after PEGylated liposomal doxorubicin.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 02, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.
Journal: Current oncology (Toronto, Ont.)
Published: January 28, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update).
Journal: Current oncology (Toronto, Ont.)
Published: January 16, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Metastatic Breast Cancer 2025.
Journal: Current oncology (Toronto, Ont.)
Published: December 24, 2025
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Early Breast Cancer 2025.
Journal: Current oncology (Toronto, Ont.)
Published: December 07, 2025
Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada.
Journal: Current oncology (Toronto, Ont.)
Published: July 03, 2025
Bridging gaps in breast cancer care: a Breast Cancer Care Quality Index to improve outcomes worldwide.
Journal: Ecancermedicalscience
Published: June 09, 2025
Canadian Recommendations for Germline Genetic Testing of Patients with Breast Cancer: A Call to Action.
Journal: Current oncology (Toronto, Ont.)
Published: March 25, 2025
Systemic treatment of immune checkpoint inhibitor-induced psoriasis: Inference-based guidance.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 04, 2025
A pragmatic, multicenter, randomized trial comparing morning versus evening dosing of adjuvant endocrine therapy (REaCT-CHRONO Study).
Journal: NPJ breast cancer
Published: January 10, 2025
Last Updated: 09/26/2026